About

About Cyagen Biomodels LLC Founded in 2006, Cyagen is a global provider of genetically modified rodent models and advanced CRO solutions for biomedical research and drug development. With more than 900 employees and research facilities covering 40,000 m², Cyagen supports researchers in over 100 countries and has contributed to more than 13,000 peer-reviewed publications, including in Cell, Nature, and Science. Headquartered in Santa Clara, California, Cyagen also operates subsidiaries in Japan and China, with major R&D and production centers in Guangzhou, Suzhou, and Gu’an. Combining expertise in cell and animal model generation with AI-driven discovery platforms, Cyagen provides scalable, reliable, one-stop solutions for basic research and preclinical drug development. Cyagen has developed several proprietary platforms to advance translational research, including HUGO-GT™ genomic humanized mouse models, the Rare Disease Data Center (RDDC) integrating genetic databases and AI tools